0001567619-21-013956.txt : 20210726
0001567619-21-013956.hdr.sgml : 20210726
20210726124732
ACCESSION NUMBER: 0001567619-21-013956
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210726
DATE AS OF CHANGE: 20210726
EFFECTIVENESS DATE: 20210726
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Manistee Therapeutics, Inc.
CENTRAL INDEX KEY: 0001874367
IRS NUMBER: 863208521
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-407718
FILM NUMBER: 211113435
BUSINESS ADDRESS:
STREET 1: 84 BARNES HILL ROAD
CITY: CONCORD
STATE: MA
ZIP: 01742
BUSINESS PHONE: 617-538-7105
MAIL ADDRESS:
STREET 1: 84 BARNES HILL ROAD
CITY: CONCORD
STATE: MA
ZIP: 01742
D
1
primary_doc.xml
X0708
D
LIVE
0001874367
Manistee Therapeutics, Inc.
84 BARNES HILL ROAD
CONCORD
MA
MASSACHUSETTS
01742
617-538-7105
DELAWARE
None
None
Corporation
true
2021
Robert
L.
Bratzler, Ph.D.
84 Barnes Hill Road
Concord
MA
MASSACHUSETTS
01742
Executive Officer
Director
Stephen
Bruso
84 Barnes Hill Road
Concord
MA
MASSACHUSETTS
01742
Director
Bradford
J.
Shingleton, M.D
84 Barnes Hill Road
Concord
MA
MASSACHUSETTS
01742
Executive Officer
Director
Other
Decline to Disclose
- 06b
false
2021-07-13
false
true
false
0
9500000
9500000
0
false
6
0
0
0
false
Manistee Therapeutics, Inc.
/s/ Robert L. Bratzler, Ph.D.
Robert L. Bratzler, Ph.D.
President & Chief Executive Officer
2021-07-26